Let me know when the data is updated again

DEFA, S.A. DE C.V.

Summary of sales of medicines and medical supplies

980 purchase as supplier for a total of 8.4 millones (8,388,857.613 ) between 2009 and 2016.

Annual evolution of purchase
Procedure type
Top buyers



Largest purchase



Total overcost

Overcost in MXN

4.5 millones pesos mexicanos (4,531,577.198 MXN)

Overcost in %

333.7 %

Top products
Product Purchases Total amount Overcost in MXN Overcost in % Period
FLUDROCORTISONA 22 92,013.1 MXN 6,454 MXN 49.3 % 2010 - 2012
BENZOILO 20 4,900.3 MXN 0 MXN 0 % 2016 - 2016
TIRA REACTIVA 17 125,701.1 MXN 7,896.3 MXN 7.92 % 2010 - 2011
GABAPENTINA 16 18,839.7 MXN 8,407.6 MXN 301.4 % 2009 - 2012
PIOGLITAZONA 15 72,137.1 MXN 40,335.4 MXN 1,000.3 % 2011 - 2012
COMPRESAS 14 517,114.9 MXN 215,940.3 MXN 74 % 2009 - 2011
SALBUTAMOL 12 187,969.2 MXN 62,331.4 MXN 200.7 % 2010 - 2012
OXCARBAZEPINA 11 33,489.5 MXN 27,479.4 MXN 519.3 % 2010 - 2012
AMIODARONA 11 18,814.5 MXN 16,731 MXN 844.5 % 2009 - 2012

Location

Country

México

GENERAL INFORMATION

Alternative names

  • DEFA S.A. DE C.V.
  • DEFA SA DE CV

Entity type

profit

Identifiers

RFC: DEF920101UYA

Date updated in QQW

24 de enero de 2019

Organization responsible for the import

PODER